Skip to content
Search

Latest Stories

Alliance Healthcare cyclists raise over £40,000 for charities

Alliance Healthcare has raised more than £40,000 for Vitamin Angels UK and Theodora Children’s Charity which focuses on health and wellbeing of children, through its annual charity Tour D’Alliance cycle challenge hosted on June 18.

Two teams of cyclists completed the community pharmacy wholesaler's annual charity event. The teams, departing from Coatbridge, Scotland and Exeter, Devon, set off across the UK towards the Alliance Healthcare Leigh service centre in Greater Manchester for a finish line event.


In addition, 16 other members of staff competed in a virtual cycle challenge across seven days.

The company said the gruelling challenge was in aid of two charities: Vitamin Angels UK and Theodora Children’s Charity; both with a mission to improve the health and wellbeing of children in the UK and across the world.

Tour DAlliance 2022 cyclists finishing line with Giggle Doctor

Tour DAlliance 2022 charities together

Tour DAlliance 2022 cycle teams together

Tour DAlliance 2022 cyclists arriving

Matt Addison, operations director, Alliance Healthcare and a cyclist, said: “I am so incredibly proud of my cycling team mates for their physical and mental endurance, particularly during this heat-wave and amidst some challenging winds in the north of England. It is for such a worthy cause, and we are so grateful for all the generous sponsorship and donations, it really kept-us-going!”

Ellen Blessington from Theodora Children’s Charity was at the finish-line welcome in Leigh and said: “I am thrilled to be here with our Giggle Doctor, Dr Scribbles, to celebrate this amazing achievement with Alliance Healthcare colleagues. Being a small charity, this fundraising support has a significant impact on our work and will help our Giggle Doctors bring joy and laughter to hundreds of children in hospital across the UK.”

Vitamin Angels' Roma Mirutenko added: “It has been amazing to watch the Tour D’Alliance event grow over the years. Through our partnership, it is clear that Alliance Healthcare is committed to improving the health and nutrition of children.”

Today, more than 4 million children in the UK live in poverty and are therefore at risk of malnutrition. Funds raised from the Tour D’Alliance can continue to fight malnutrition by providing nutritious foods to twelve nurseries across the country.

More For You

Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less